BeOne Medicines (ONC) Reiterated at Market Outperform by Citizens on Serial Innovation

September 15, 2026 5:31 AM

Citizens analyst Reni Benjamin reiterated a Market Outperform rating and $405.00 price target on BeOne Medicines (NASDAQ: ONC).The analyst commented ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found